Preterm Birth and PROM Testing Market Industry Insights and Growth Forecast, 2034

The global Preterm Birth and PROM Testing Market is experiencing significant growth due to rising incidences of preterm births, increasing awareness regarding maternal and neonatal healthcare, and growing adoption of advanced prenatal diagnostic technologies worldwide. According to the latest report by Straits Research, the global preterm birth and PROM testing market was valued at USD 1.56 billion in 2024 and is projected to grow from USD 1.69 billion in 2025 to reach USD 3.26 billion by 2033, registering a CAGR of 8.6% during the forecast period (2025–2033).

Preterm birth and Premature Rupture of Membranes (PROM) testing involves diagnostic procedures and biomarker-based tests used to assess the risk of premature labor and membrane rupture during pregnancy. These testing solutions play a critical role in early diagnosis, timely interventions, and improved maternal and neonatal outcomes, significantly accelerating market growth globally.

Market Drivers

Rising Incidence of Preterm Births Worldwide

One of the key drivers of the preterm birth and PROM testing market is the increasing prevalence of preterm births globally. Growing numbers of high-risk pregnancies, lifestyle-related complications, and maternal health disorders are increasing demand for early screening and diagnostic solutions.

Growing Awareness Regarding Maternal and Neonatal Health

Another significant growth factor is increasing awareness regarding maternal health and prenatal care. Healthcare providers are increasingly emphasizing early detection methods to reduce neonatal complications and improve pregnancy outcomes.

Technological Advancements in Prenatal Diagnostics

The rapid advancement of diagnostic technologies is further supporting market growth. Biomarker-based testing, advanced ultrasound imaging, and non-invasive screening methods are improving diagnostic accuracy and enabling earlier interventions.

Expansion of Healthcare Infrastructure and Prenatal Care Services

Growing investments in healthcare infrastructure and expanding access to prenatal care services are also accelerating market expansion. Emerging economies are increasingly improving maternal healthcare capabilities and diagnostic accessibility.

Increasing Adoption of Personalized Pregnancy Monitoring

Furthermore, personalized medicine approaches and patient-specific risk assessment tools are creating additional growth opportunities for market participants. Healthcare providers increasingly rely on predictive testing methods to improve individualized treatment planning.

Market Challenges

High Cost of Advanced Diagnostic Tests

Despite strong growth prospects, the preterm birth and PROM testing market faces several challenges. One of the primary restraints is the relatively high cost associated with advanced diagnostic technologies and biomarker-based testing methods.

Limited Awareness in Developing Regions

Another challenge is limited awareness and inadequate prenatal care access across low-income and developing regions, restricting broader market penetration.

Regulatory and Clinical Validation Requirements

The market also faces regulatory challenges due to stringent approval requirements and clinical validation processes for new testing technologies.

Limited Access to Skilled Healthcare Professionals

Additionally, shortages of trained healthcare professionals and specialized prenatal diagnostic expertise may create barriers to efficient testing adoption.

Market Segmentation

The preterm birth and PROM testing market is segmented based on test type, product type, end-user, and region.

By Test Type

The market is categorized into ultrasound testing, biochemical marker testing, pelvic examination, uterine monitoring, and others. Ultrasound testing dominates the market due to widespread clinical use and high diagnostic reliability.

By Product Type

The market includes instruments, kits and reagents, and services. Kits and reagents account for a significant market share owing to increasing test volumes and growing biomarker adoption.

By End User

The market is segmented into hospitals, diagnostic laboratories, maternity clinics, specialty healthcare centers, and others. Hospitals dominate the market owing to higher patient volumes and advanced diagnostic capabilities.

By Region

The market is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Regional Insights

North America

North America dominates the preterm birth and PROM testing market due to advanced healthcare infrastructure, high awareness regarding maternal health, and widespread adoption of advanced diagnostic technologies.

Europe

Europe represents a significant market share supported by strong healthcare systems, favorable reimbursement policies, and increasing investments in prenatal healthcare services.

Asia-Pacific

Asia-Pacific is expected to witness strong growth during the forecast period. Rising birth rates, improving healthcare infrastructure, growing maternal health awareness, and increasing healthcare investments across China, India, Japan, and Southeast Asia are driving regional market expansion.

Latin America and Middle East & Africa

Latin America and the Middle East & Africa are emerging markets due to increasing healthcare expenditure, expanding prenatal care services, and improving access to maternal health diagnostics.

Key Players Analysis

The preterm birth and PROM testing market is highly competitive, with major companies focusing on biomarker innovations, advanced diagnostic technologies, and strategic collaborations to strengthen their market presence.

Major companies operating in the market include Abbott Laboratories, Biosynex, Qiagen N.V., Hologic Inc., Clinical Innovations LLC, Sera Prognostics, IQ Products, NX Prenatal Inc., Promega Corporation, and Creative Diagnostics.

These companies are increasingly investing in predictive diagnostics, point-of-care testing technologies, and advanced maternal healthcare solutions to improve market competitiveness.

For Detailed Insights, Visit:

https://straitsresearch.com/report/preterm-birth-and-prom-testing-market

About Us

Straits Research is a leading market research and intelligence organization specializing in analytics, advisory services, and comprehensive market research reports across multiple industries. The company provides actionable business insights and strategic market intelligence to help organizations identify growth opportunities and make informed business decisions.

Contact Us

Email: sales@straitsresearch.com

Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)

Article source: https://article-realm.com/article/Business/83255-Preterm-Birth-and-PROM-Testing-Market-Industry-Insights-and-Growth-Forecast-2034.html